These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 19593974)

  • 1. Percutaneous embolization on hereditary hemorrhagic telangiectasia patients with severe epistaxis.
    Braak SJ; de Witt CA; Disch FJ; Overtoom TT; Westermann JJ
    Rhinology; 2009 Jun; 47(2):166-71. PubMed ID: 19593974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The SF-36 health status questionnaire in assessing patients with epistaxis secondary to hereditary hemorrhagic telangiectasia.
    Lennox PA; Hitchings AE; Lund VJ; Howard DJ
    Am J Rhinol; 2005; 19(1):71-4. PubMed ID: 15794078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of septodermoplasty and potassium-titanyl-phosphate (KTP) laser therapy in the treatment of hereditary hemorrhagic telangiectasia-related epistaxis.
    Harvey RJ; Kanagalingam J; Lund VJ
    Am J Rhinol; 2008; 22(2):182-7. PubMed ID: 18416977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epistaxis in patients with hereditary hemorrhagic telangiectasia treated with selective arterial embolization.
    Trojanowski P; Jargiello T; Trojanowska A; Klatka J
    Acta Radiol; 2011 Oct; 52(8):846-9. PubMed ID: 21816895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of septal dermoplasty in patients with hereditary hemorrhagic telangiectasia.
    Fiorella ML; Ross D; Henderson KJ; White RI
    Laryngoscope; 2005 Feb; 115(2):301-5. PubMed ID: 15689755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of epistaxis in Rendu-Osler disease by intramucosal injection of ethibloc].
    Borsik M; Herbreteau D; Deffrennes D; Guichard JP; Aymard A; Merland JJ; Tran Ba Huy P
    Ann Otolaryngol Chir Cervicofac; 1992; 109(5):273-6. PubMed ID: 1292384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The natural history of epistaxis in hereditary hemorrhagic telangiectasia.
    AAssar OS; Friedman CM; White RI
    Laryngoscope; 1991 Sep; 101(9):977-80. PubMed ID: 1886446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of treatment for epistaxis secondary to hereditary hemorrhagic telangiectasia.
    Hitchings AE; Lennox PA; Lund VJ; Howard DJ
    Am J Rhinol; 2005; 19(1):75-8. PubMed ID: 15794079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiestrogen therapy for hereditary hemorrhagic telangiectasia: a double-blind placebo-controlled clinical trial.
    Yaniv E; Preis M; Hadar T; Shvero J; Haddad M
    Laryngoscope; 2009 Feb; 119(2):284-8. PubMed ID: 19160429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of severity of epistaxis with nasal telangiectasias in hereditary hemorrhagic telangiectasia (HHT) patients.
    Pagella F; Colombo A; Matti E; Giourgos G; Tinelli C; Olivieri C; Danesino C
    Am J Rhinol Allergy; 2009; 23(1):52-8. PubMed ID: 19379613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of N-acetylcysteine on epistaxis and quality of life in patients with HHT: a pilot study.
    de Gussem EM; Snijder RJ; Disch FJ; Zanen P; Westermann CJ; Mager JJ
    Rhinology; 2009 Mar; 47(1):85-8. PubMed ID: 19382502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New classification of nasal vasculature patterns in hereditary hemorrhagic telangiectasia.
    Mahoney EJ; Shapshay SM
    Am J Rhinol; 2006; 20(1):87-90. PubMed ID: 16539301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endovascular treatment of epistaxis in patients with hereditary hemorrhagic telangiectasia.
    Layton KF; Kallmes DF; Gray LA; Cloft HJ
    AJNR Am J Neuroradiol; 2007 May; 28(5):885-8. PubMed ID: 17494663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hereditary hemorrhagic telangiectasia: a review of 76 cases.
    Shah RK; Dhingra JK; Shapshay SM
    Laryngoscope; 2002 May; 112(5):767-73. PubMed ID: 12150604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intractable epistaxis in Osler-Rendu-Weber syndrome].
    Zalagh M; Errami N; Bouaity B; Hemmaoui B; Itoua W; Benariba F
    Rev Stomatol Chir Maxillofac; 2011 Nov; 112(5):310-2. PubMed ID: 21940027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural history and control of epistaxis in a group of German patients with Rendu-Osler-Weber disease.
    Folz BJ; Tennie J; Lippert BM; Werner JA
    Rhinology; 2005 Mar; 43(1):40-6. PubMed ID: 15844501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The utility of bipolar electrocautery in hereditary hemorrhagic telangiectasia.
    Ghaheri BA; Fong KJ; Hwang PH
    Otolaryngol Head Neck Surg; 2006 Jun; 134(6):1006-9. PubMed ID: 16730547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of a topical sesame/rose geranium oil compound in patients with hereditary hemorrhagic telangiectasia associated epistaxis.
    Reh DD; Hur K; Merlo CA
    Laryngoscope; 2013 Apr; 123(4):820-2. PubMed ID: 23401038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neodymium-YAG laser intranasal photocoagulation in hereditary hemorrhagic telangiectasia: an update report.
    Kluger PB; Shapshay SM; Hybels RL; Bohigian RK
    Laryngoscope; 1987 Dec; 97(12):1397-401. PubMed ID: 3683050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term complications of septal dermoplasty in patients with hereditary hemorrhagic telangiectasia.
    Levine CG; Ross DA; Henderson KJ; Leder SB; White RI
    Otolaryngol Head Neck Surg; 2008 Jun; 138(6):721-4. PubMed ID: 18503842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.